Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium add-on to Seroquel XR for acute mania in bipolar I disorder
2008-007190-20Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2009
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar I disorder and mania comparing Lithium + Seroquel XR with Placebo + Seroquel XR (2 arms). Primary endpoint: Change from baseline to final assessment in Young Mania Rating Scale total score. Started Mar 2009; status: completed.
02
Drugs
lithiumquetiapine
03
Conditions
bipolar I disordermania
Beyond the preview
Go deeper on 2008-007190-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007190-20.